EXTENDED TREATMENT WITH PEGINTERFERON ALFA-2A BENEFITS PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B WITH A PARTIAL RESPONSE AFTER 48 WEEKS OF THERAPY - CLINICAL EXPERIENCE FROM A CHINESE CENTER
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- October 2009
has subject area
- 1101 Medical Biochemistry and Metabolomics (FoR)
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Hepatology Journal